Table 2.
Control group (n = 150) | COVID-19 group (n = 50) | p-Value | |
---|---|---|---|
Age (years), mean ± SD | 52.4 ± 20.2 | 52.2 ± 20.7 | 0.965 |
25-Hydroxyvitamin D3 (ng/dl), mean ± SD | 25.0 ± 13.2 | 15.7 ± 7.9) | <0.001 |
25-Hydroxyvitamin D3 deficiency, n/n (%) | |||
Deficiency (≤20 ng/dl) | 65/150 (43.3%) | 37/50 (74.0%) | 0.003 |
Severe deficiency (≤10 ng/dl) | 11/150 (7.3%) | 12/50 (24.0%) | 0.001 |
SD, standard deviation.